An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitors
-
Patents Against People: How Drug Companies Price Patients out of Survival – Courtesy (Dissent)
Pharma Live, , Intellectual Property Rights, 0
As our television screens toggle between pundits squabbling over Obamacare’s insurance rules and ads for erectile dysfunction remedies, another...
-
Louisiana Challenge’s AstraZeneca on Antitrust Claims for Asserting Invalid Drug Patents – Courtesy(PATENTLYO)
Pharma Live, , Intellectual Property Rights, 0
In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of...
-
Suven Life Sciences gets patents for neurological drug
Pharma Live, , Intellectual Property Rights, 0
Suven Life Sciences gets patents for neurological drug
-
Federal Circuit Finds That FDA Citizen Petition Could Give Rise To Antitrust Liability – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 7 AUGUST 2014POSTED IN ANTITRUST;FDA;FEDERAL CIRCUIT DECISIONSIn Tyco Healthcare Group LP v. Mutual Pharmaceutical Co., Inc., the...
-
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug ‘Stempeucel’ – Courtesy(Biospace)
Pharma Live, , Intellectual Property Rights, 0
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced...
-
Court Denies Generic Drug Manufacturer’s Motion to Dismiss Hatch-Waxman Patent Infringement Action on Jurisdiction Grounds
Pharma Live, , Intellectual Property Rights, 0
the United States District Court for the Southern District of Indiana joined the District of Delaware and Eastern District...
-
Teva Pharmaceutical (TEVA) Sued By VIVUS, Inc. (VVUS) For Qsymia Patent Infringement – Courtesy(bidnessetc.com)
Pharma Live, , Intellectual Property Rights, 0
Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has been sued in the US District Court for the District of New...
-
The Remicade Biosimilar Patent Dispute
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 10 MARCH 2015POSTED IN BIOSIMILARSWhile Sandoz has grabbed the biosimilar headlines for being the first company to have a...
![](https://interactivepharm.com/wp-content/uploads/2022/08/Show-your.jpg)